Louisiana State Employees Retirement System acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the 1st quarter, Holdings Channel.com reports. The fund acquired 57,900 shares of the medical instruments supplier’s stock, valued at approximately $672,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in XRAY. First Eagle Investment Management LLC boosted its stake in DENTSPLY SIRONA by 3.2% in the 4th quarter. First Eagle Investment Management LLC now owns 14,640,555 shares of the medical instruments supplier’s stock worth $167,342,000 after purchasing an additional 458,744 shares during the period. AQR Capital Management LLC raised its stake in shares of DENTSPLY SIRONA by 109.8% in the 2nd quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock valued at $211,470,000 after purchasing an additional 6,970,086 shares during the period. Lazard Asset Management LLC lifted its holdings in shares of DENTSPLY SIRONA by 0.9% in the third quarter. Lazard Asset Management LLC now owns 10,200,525 shares of the medical instruments supplier’s stock valued at $129,445,000 after purchasing an additional 92,868 shares in the last quarter. Armistice Capital LLC boosted its position in shares of DENTSPLY SIRONA by 27.2% during the fourth quarter. Armistice Capital LLC now owns 7,298,000 shares of the medical instruments supplier’s stock worth $83,416,000 after buying an additional 1,562,000 shares during the period. Finally, State Street Corp boosted its position in shares of DENTSPLY SIRONA by 5.5% during the second quarter. State Street Corp now owns 7,099,906 shares of the medical instruments supplier’s stock worth $113,868,000 after buying an additional 369,876 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY traded down $0.15 on Tuesday, reaching $12.16. The stock had a trading volume of 234,719 shares, compared to its average volume of 5,007,478. The company has a debt-to-equity ratio of 1.52, a current ratio of 1.53 and a quick ratio of 0.98. The company has a market cap of $2.44 billion, a P/E ratio of -3.87, a price-to-earnings-growth ratio of 1.39 and a beta of 0.89. The firm has a fifty day moving average of $10.58 and a two-hundred day moving average of $11.65. DENTSPLY SIRONA Inc. has a 1-year low of $9.40 and a 1-year high of $17.09.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last announced its earnings results on Tuesday, May 5th. The medical instruments supplier reported $0.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.01). DENTSPLY SIRONA had a negative net margin of 17.06% and a positive return on equity of 18.83%. The business had revenue of $880.00 million during the quarter, compared to the consensus estimate of $841.80 million. During the same period in the previous year, the firm posted $0.43 EPS. The company’s revenue was up .1% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.42 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on XRAY shares. Mizuho dropped their target price on DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 6th. UBS Group cut their price objective on shares of DENTSPLY SIRONA from $18.00 to $17.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Weiss Ratings downgraded shares of DENTSPLY SIRONA from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 6th. Barclays reduced their target price on DENTSPLY SIRONA from $12.00 to $9.00 and set an “underweight” rating for the company in a research note on Thursday, June 4th. Finally, Citigroup started coverage on DENTSPLY SIRONA in a report on Wednesday, April 15th. They set a “sell” rating and a $10.00 price target for the company. Three investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $13.55.

Get Our Latest Report on DENTSPLY SIRONA

Insider Buying and Selling at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Brian P. Mckeon bought 10,000 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were purchased at an average price of $10.12 per share, for a total transaction of $101,200.00. Following the transaction, the director directly owned 10,000 shares in the company, valued at approximately $101,200. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Brian T. Gladden bought 9,985 shares of the stock in a transaction dated Monday, June 15th. The shares were acquired at an average cost of $10.02 per share, for a total transaction of $100,049.70. Following the completion of the acquisition, the director directly owned 61,849 shares of the company’s stock, valued at approximately $619,726.98. This trade represents a 19.25% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 35,160 shares of company stock valued at $351,179 in the last quarter. Company insiders own 0.46% of the company’s stock.

DENTSPLY SIRONA Profile

(Free Report)

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.

Further Reading

• Five stocks we like better than DENTSPLY SIRONA
• GE Vernova’s Power Surge Turns the Grid Into an AI Trade
• Orbiting Capital: Lawmakers Buy SpaceX Ahead of Index Inclusion
• Big Beautiful Boycott: Can It Really Hurt Coca-Cola, Amazon, and Kraft Heinz Stocks?
• 3 Stocks With Solid Yields and Sustainabale Payouts Boost Dividends Once Again

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINE

Arthur J. Gallagher & Co. $AJG Shares Sold by Sterling Capital Management LLC

NEXT HEADLINE »

Louisiana State Employees Retirement System Purchases Shares of 6,000 Mid-America Apartment Communities, Inc. $MAA

You might be interested in: